The company’s ACC lineup underscores a growing body of evidence backing the drug’s performance beyond controlled trials
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
The company says those insights can power advanced analytics and real-world evidence (RWE), helping researchers improve trial design, study feasibility, and recruitment strategies
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
CagriSema produced a 23% weight loss at 84 weeks, versus 25.5% for tirzepatide
Both non-transfusion-dependent and transfusion dependent cohorts met their respective primary and secondary endpoints
The data highlights its RSV vaccine cuts hospitalizations in older adults
Duvakitug was well tolerated and safety was consistent with the induction study
Under the 2023 collaboration agreement, Assembly Bio will receive $35 million for Gilead’s exercise of the HSV program option
Subscribe To Our Newsletter & Stay Updated
